Clinical trial cost is a fraction of the drug development bill, with an average price tag of $19m

A study performed by a team of researchers from John Hopkins Bloomberg School of Public Health on comprehensive assessment of the cost of pivotal clinical trials indicated that the clinical trials supported by FDA approval of new drugs have a medium cost of $19m.